STERIS’ (TSE:STE – Free Report) – Analysts at Raymond James reduced their FY2025 earnings per share estimates for STERIS’ in a research report issued to clients and investors on Wednesday, March 12th. Raymond James analyst M. Barth now forecasts that the company will post earnings of $0.64 per share for the year, down from their prior estimate of $0.76. Raymond James also issued estimates for STERIS’’s FY2029 earnings at $0.68 EPS.
Other equities analysts have also issued research reports about the company. Cormark raised STERIS’ to a “moderate buy” rating in a research note on Monday, January 6th. Atb Cap Markets raised STERIS’ to a “strong-buy” rating in a research report on Sunday, December 22nd.
STERIS’ Stock Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Recommended Stories
- Five stocks we like better than STERIS’
- What is the S&P/TSX Index?
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- 3 Grocery Stocks That Are Proving They Are Still Essential
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Earnings Per Share Calculator: How to Calculate EPS
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
